Login
Tectonic Therapeutic, Inc. logo

Tectonic Therapeutic, Inc.

tectonictx.com

What Do They Do?

Develops therapeutic proteins and antibodies that act on cell-surface receptors, pursuing medicines for people with pulmonary hypertension and hereditary hemorrhagic telangiectasia.

How Are They Changing?

From gene therapy to biologics The business shifted from developing gene therapies made from patients’ own stem cells for rare genetic diseases to developing therapeutic proteins and antibodies that target GPCRs, including candidates for pulmonary hypertension and hereditary hemorrhagic telangiectasia.

Who Do They Compete With?

Competes with AstraZeneca, Vaderis, Terremoto, Atavistik, Diagonal Therapeutics, Alnylam Pharmaceuticals, Boehringer Ingelheim, Novartis, Septerna, SOSEI-Heptares, Structure Therapeutics, Abalone Bio, Orion Biotechnology, Abilitia Bio, Confo Therapeutic, Omeros, and GPCR Therapeutics

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support